---
title: "Gyre Therapeutics (GYRE) Receives a Buy from Noble Financial"
description: "LeBoyer covers the Healthcare sector, focusing on stocks such as Ocugen, Eledon Pharmaceuticals, and Unicycive Therapeutics. According to TipRanks, LeBoyer has an average return of -10.6% and a 26.51%"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/256588476.md"
published_at: "2025-09-09T13:55:13.000Z"
---

# Gyre Therapeutics (GYRE) Receives a Buy from Noble Financial

> LeBoyer covers the Healthcare sector, focusing on stocks such as Ocugen, Eledon Pharmaceuticals, and Unicycive Therapeutics. According to TipRanks, LeBoyer has an average return of -10.6% and a 26.51% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Gyre Therapeutics with a $23.00 average price target, a 190.77% upside from current levels. In a report released on August 26, H.C. Wainwright also initiated coverage with a Buy rating on the stock with a $18.00 price target.

LeBoyer covers the Healthcare sector, focusing on stocks such as Ocugen, Eledon Pharmaceuticals, and Unicycive Therapeutics. According to TipRanks, LeBoyer has an average return of \-10.6% and a 26.51% success rate on recommended stocks.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Gyre Therapeutics with a $23.00 average price target, a 190.77% upside from current levels. In a report released on August 26, H.C. Wainwright also initiated coverage with a Buy rating on the stock with a $18.00 price target.

### Related Stocks

- [GYRE.US - Gyre Therapeutics](https://longbridge.com/en/quote/GYRE.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Gyre Therapeutics (GYRE) Gets a Buy from H.C. Wainwright | Keller covers the Healthcare sector, focusing on stocks such as FibroGen, Acurx Pharmaceuticals, and Gyre Therapeutics.  | [Link](https://longbridge.com/en/news/263275045.md) |
| Establishment Labs to Present at TD Cowen’s 46th Annual Health Care Conference | Establishment Labs Holdings Inc. (NASDAQ: ESTA) will present at TD Cowen’s 46th Annual Health Care Conference on March 2 | [Link](https://longbridge.com/en/news/276230625.md) |
| Medline CEO Jim Boyle and CFO Mike Drazin to Present at Barclays Global Healthcare Conference | Medline Inc. announced that CEO Jim Boyle and CFO Mike Drazin will present at the Barclays 28th Annual Global Healthcare | [Link](https://longbridge.com/en/news/276227400.md) |
| Genelux to Present at TD Cowen 46th Annual Health Care Conference | Genelux Corporation (NASDAQ: GNLX) will participate in the Oppenheimer Healthcare Life Sciences Conference on Feb. 25, 2 | [Link](https://longbridge.com/en/news/276230499.md) |
| CNL Healthcare Sets NAV, Details Sonida Merger Plans | CNL Healthcare Properties has set an adjusted estimated net asset value (NAV) of $6.90 per share as of November 4, 2025, | [Link](https://longbridge.com/en/news/276164395.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.